Viveve Medical Top Management
VIVEDelisted Stock | USD 0.1 0.0005 0.53% |
Viveve Medical employs about 47 people. The company is managed by 9 executives with a total tenure of roughly 12 years, averaging almost 1.0 years of service per executive, having 5.22 employees per reported executive. Evaluation of Viveve Medical's management performance can provide insight into the firm performance.
Scott Durbin CEO CEO Director |
Viveve |
Viveve Medical Management Team Effectiveness
The company has return on total asset (ROA) of (0.6213) % which means that it has lost $0.6213 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (2.1099) %, meaning that it created substantial loss on money invested by shareholders. Viveve Medical's management efficiency ratios could be used to measure how well Viveve Medical manages its routine affairs as well as how well it operates its assets and liabilities.Viveve Medical Workforce Comparison
Viveve Medical is rated below average in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 878. Viveve Medical holds roughly 47.0 in number of employees claiming about 5% of equities under Health Care industry.
Viveve Medical Notable Stakeholders
A Viveve Medical stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Viveve Medical often face trade-offs trying to please all of them. Viveve Medical's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Viveve Medical's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Scott Durbin | CEO Director | Profile | |
Jim Robbins | Principal Financial Officer | Profile | |
Martin PE | Dev Research | Profile | |
Suzon Lommel | VP Affairs | Profile | |
Lori McMillan | VP HR | Profile | |
Deborah MBA | Advisor Director | Profile | |
Jeannie Swindle | Sr Communications | Profile | |
Gary Kaiser | VP Marketing | Profile | |
Jeff Sinclair | VP Sales | Profile |
About Viveve Medical Management Performance
The success or failure of an entity such as Viveve Medical often depends on how effective the management is. Viveve Medical management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Viveve management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Viveve management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Viveve Medical, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices for the non-invasive treatment of vaginal introital laxity, sexual function, vaginal rejuvenation, and stress urinary incontinence. Viveve Medical, Inc. was founded in 2005 and is headquartered in Englewood, Colorado. Viveve Medical operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 47 people.
Please note, the presentation of Viveve Medical's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Viveve Medical's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Viveve Medical's management manipulating its earnings.
Viveve Medical Workforce Analysis
Traditionally, organizations such as Viveve Medical use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Viveve Medical within its industry.Viveve Medical Manpower Efficiency
Return on Viveve Medical Manpower
Revenue Per Employee | 136.7K | |
Revenue Per Executive | 714K | |
Net Loss Per Employee | 468.7K | |
Net Loss Per Executive | 2.4M | |
Working Capital Per Employee | 281K | |
Working Capital Per Executive | 1.5M |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Consideration for investing in Viveve Pink Sheet
If you are still planning to invest in Viveve Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Viveve Medical's history and understand the potential risks before investing.
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |